Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 1
1996 2
1997 6
1998 2
1999 1
2000 3
2001 4
2002 4
2003 6
2004 10
2005 13
2006 15
2007 13
2008 17
2009 25
2010 17
2011 13
2012 24
2013 21
2014 23
2015 37
2016 28
2017 20
2018 27
2019 20
2020 27
2021 39
2022 17
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Results by year

Filters applied: . Clear all
Page 1
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Eisen A, Somerfield MR, Accordino MK, Blanchette PS, Clemons MJ, Dhesy-Thind S, Dillmon MS, D'Oronzo S, Fletcher GG, Frank ES, Hallmeyer S, Makhoul I, Moy B, Thawer A, Wu JY, Van Poznak CH. Eisen A, et al. Among authors: clemons mj. J Clin Oncol. 2022 Mar 1;40(7):787-800. doi: 10.1200/JCO.21.02647. Epub 2022 Jan 18. J Clin Oncol. 2022. PMID: 35041467
Beckett M, Cole K, White M, Chan J, McVicar J, Rodin D, Clemons M, Bourque JM. Beckett M, et al. Among authors: clemons m. J Cancer Policy. 2021 Dec;30:100309. doi: 10.1016/j.jcpo.2021.100309. Epub 2021 Sep 25. J Cancer Policy. 2021. PMID: 35559804 Free article. Review.
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, Donato di Paola E, Verweij J, Nielsen S. Judson I, et al. Among authors: clemons mj. Eur J Cancer. 2001 May;37(7):870-7. doi: 10.1016/s0959-8049(01)00050-8. Eur J Cancer. 2001. PMID: 11313175 Clinical Trial.
Surviving Surveys.
Mazzarello S, Clemons M, Graham ID, Jacobs C. Mazzarello S, et al. Among authors: clemons m. J Oncol Pract. 2015 Jan;11(1):44-6. doi: 10.1200/JOP.2014.001484. Epub 2014 Aug 5. J Oncol Pract. 2015. PMID: 25095823 No abstract available.
More about osteonecrosis.
Finkelman RD, Clemons M, Bouganim N. Finkelman RD, et al. Among authors: clemons m. J Am Dent Assoc. 2011 Apr;142(4):371-2; author reply 372-4. doi: 10.14219/jada.archive.2011.0183. J Am Dent Assoc. 2011. PMID: 21454842 No abstract available.
Tamoxifen ("Nolvadex"): a review.
Clemons M, Danson S, Howell A. Clemons M, et al. Cancer Treat Rev. 2002 Aug;28(4):165-80. doi: 10.1016/s0305-7372(02)00036-1. Cancer Treat Rev. 2002. PMID: 12363457 Review.
Which behavioral health screening tool should you use-and when?
Sewell R, Cottrell E, Gutman K, Clemons M, Friedman D, Kotin E, Smith E, Whitehouse J, Pratt C. Sewell R, et al. Among authors: clemons m. J Fam Pract. 2020 Nov;69(9):454-460. J Fam Pract. 2020. PMID: 33176341 Review.
398 results